Literature DB >> 8806560

The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA.

M C Stöppler1, S W Straight, G Tsao, R Schlegel, D J McCance.   

Abstract

Human papillomavirus type 16 (HPV-16) is the most common papillomavirus genome found in human cervical cancers and its DNA is capable of immortalizing primary keratinocytes in vitro. When expressed by their native promoter, two separate HPV-16 oncogenes, E6 and E7, cooperate to immortalize primary human keratinocytes. Early HPV cervical lesions express abundant amounts of E5-specific RNA, and using a quantitative keratinocyte immortalization assay, we demonstrate here that E5 can act in cis to increase (4-10 fold) the efficiency of cellular immortalization by E6/E7. These results suggest that the expression of the HPV-16 E5 gene may play a role in the pathogenesis of early HPV infections by potentiating the effects of E6/E7.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8806560     DOI: 10.1006/viro.1996.0475

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  37 in total

Review 1.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

2.  A role for HPV16 E5 in cervical carcinogenesis.

Authors:  John P Maufort; Anny Shai; Henry C Pitot; Paul F Lambert
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

3.  Human papillomavirus 16 E5 induces bi-nucleated cell formation by cell-cell fusion.

Authors:  Lulin Hu; Kendra Plafker; Valeriya Vorozhko; Rosemary E Zuna; Marie H Hanigan; Gary J Gorbsky; Scott M Plafker; Peter C Angeletti; Brian P Ceresa
Journal:  Virology       Date:  2008-11-28       Impact factor: 3.616

Review 4.  Role of Zn2+ ions in host-virus interactions.

Authors:  Maciej Lazarczyk; Michel Favre
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

5.  The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms.

Authors:  Kirsten Kabsch; Angel Alonso
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 6.  Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value.

Authors:  Niladri Ganguly
Journal:  Cell Oncol (Dordr)       Date:  2012-01-20       Impact factor: 6.730

Review 7.  Human papillomavirus oncoproteins: pathways to transformation.

Authors:  Cary A Moody; Laimonis A Laimins
Journal:  Nat Rev Cancer       Date:  2010-07-01       Impact factor: 60.716

Review 8.  Human papillomavirus type 16 E5 protein as a therapeutic target.

Authors:  Sang-Woo Kim; Joo-Sung Yang
Journal:  Yonsei Med J       Date:  2006-02-28       Impact factor: 2.759

9.  HPV infection and EGFR activation/alteration in HIV-infected East African patients with conjunctival carcinoma.

Authors:  Jing Jie Yu; Pingfu Fu; John J Pink; Dawn Dawson; Jay Wasman; Jackson Orem; Walter O Mwanda; Honglan Zhu; Xiaobing Liang; Yi Guo; William P Petros; Ronald T Mitsuyasu; Henry Wabinga; Scot C Remick
Journal:  PLoS One       Date:  2010-05-17       Impact factor: 3.240

10.  High-risk HPV E5-induced cell fusion: a critical initiating event in the early stage of HPV-associated cervical cancer.

Authors:  Peng Gao; Jie Zheng
Journal:  Virol J       Date:  2010-09-16       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.